Latest Co-Diagnostics News & Updates

See the latest news and media coverage for Co-Dx. We track all announcements, press releases, and industry mentions in real time, all in one place.

Co-Diagnostics (Co-Dx)

Real-time PCR diagnostic test developer

codiagnostics.com

Headquarters: Salt Lake City, United States
Founded year: 2013
Company type: Public company
Number of employees: 90–200

Last updated Today

Latest news about Co-Diagnostics (Co-Dx)

In short: Co-Dx expanded its global diagnostic footprint through new Saudi Arabian infrastructure, South Asian trade deals, and Ebola test development.

Company announcements

May 20 Co-Dx

Co-Dx announces $3.0 million private placement

The offering includes common stock and warrants, priced at $1.821 per unit.

May 19 Co-Dx

Co-Dx develops Ebola assay strategy after global outbreak alert

The strategy for Bundibugyo virus is complete, allowing rapid test availability if needed, following WHO and CDC alerts.

May 14 Co-Dx

Co-Dx reported Q1 2026 revenue of $0.15 million

Operating loss increased to $9.2 million, driven by R&D spending on clinical studies.

May 8 Co-Dx

Co-Dx joint venture CoMira finalizes lease for Saudi manufacturing facility

The facility in Sudair Industrial City supports Vision 2030 localization goals and spans 14,400 square feet for diagnostic manufacturing.

Media coverage

May 22 The Globe and Mail

Co-Diagnostics Announces $3 Million Private Placement Financing

Detailed price information for Co-Diagnostics Inc (CODX-Q) from The Globe and Mail including charting and trades.

May 20 MSN

What's going on with Co-Diagnostics stock Wednesday?

Co-Diagnostics, Inc. CODX stock is trading higher on Wednesday as the company announced a private placement aimed at raising ...

May 20 Wyoming News

Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx", or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular...

May 19 Yahoo Finance

Co-Diagnostics Develops Ebola Assay Strategy Following WHO Emergency Alert (CODX)

The company said it is prepared to rapidly deploy a Bundibugyo virus Ebola test if outbreak conditions require expanded diagnostic response capabilities. Key Investor TakeawaysCo-Diagnostics...

Never miss news about Co-Dx

Track Co-Dx and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Co-Dx competitors & trending companies

Browse news for competitors to Co-Dx and other trending companies.